3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NIH
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
22
Neoplasms
13
Colonic Neoplasms
10
Breast Neoplasms
10
Venous Thromboembolism
8
Prostatic Neoplasms
8
Multiple Myeloma
7
Recurrence
6
Polycythemia Vera
6
Carcinoma, Non-Small-Cell Lung
6
Thrombocythemia, Essential
4
Neoplasms, Plasma Cell
4
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Melanoma
3
Thrombosis
2
Sarcoma
2
Rectal Neoplasms
2
Primary Myelofibrosis
2
Pancreatic Neoplasms
2
Neoplastic Cells, Circulating
2
Neoplasms by Site
2
Myocardial Infarction
2
Lung Neoplasms
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Inflammation
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Interventions
Whole-Body Irradiation
6
Peripheral Blood Stem Cell Transplantation
6
Biopsy
6
fludarabine phosphate
5
Immunohistochemistry
5
Epoetin Alfa
5
Cyclophosphamide
5
Tacrolimus
4
Methotrexate
4
Gene Expression Profiling
4
Celecoxib
4
Mycophenolic Acid
3
Microarray Analysis
3
Imiquimod
3
Etoposide
3
Darbepoetin alfa
3
Cyclosporine
3
Colposcopy
3
Busulfan
3
Antilymphocyte Serum
3
Aminolevulinic Acid
3
Tomography, Optical Coherence
2
Sirolimus
2
Polymerase Chain Reaction
2
Methylprednisolone
2
Melphalan
2
Mass Spectrometry
2
Immunoenzyme Techniques
2
Filgrastim
2
Fatty Acids, Omega-3
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Precancerous Conditions
×
Aspirin
×
Clear all
NCT00357682
2025-05-01
AspECT
University of Oxford
Phase 3
Completed
2,557 enrolled
17 charts